Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes

Glioblastoma multiforme (GBM) is one of the most aggressive primary tumors of the central nervous system. It is associated with a very poor prognosis, with up to half of patients failing to survive the first year after diagnosis. It develops from glial tissue and belongs to the adult-type diffuse gl...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Marcin Jezierzański, Natalia Nafalska, Małgorzata Stopyra, Tomasz Furgoł, Michał Miciak, Jacek Kabut, Iwona Gisterek-Grocholska
Format:	Article
Language:	English
Published:	MDPI AG 2024-07-01
Subjects:	temozolomide: glioblastoma multiforme anticancer therapy effectiveness overall survival
Online Access:	https://www.mdpi.com/1718-7729/31/7/296